DeVore Susan D. 4
4 · Solventum Corp · Filed May 1, 2026
Research Summary
AI-generated summary of this filing
Solventum (SOLV) Director Susan DeVore Converts 3,403 RSUs
What Happened
Susan D. DeVore, a director of Solventum Corp (SOLV), recorded the conversion/exercise of 3,403 derivative units on 2026-04-30. The filing shows an acquisition of 3,403 shares at $0.00 and a matching disposition of 3,403 shares at $0.00. Footnotes identify the instruments as fully vested Restricted Stock Units (RSUs) that represent the right to receive one share each upon settlement.
Key Details
- Transaction date: 2026-04-30 (code M = exercise/conversion of a derivative).
- Shares acquired: 3,403 @ $0.00; Shares disposed: 3,403 @ $0.00 (no cash amount reported).
- Footnotes: F1 — each RSU = contingent right to 1 common share on settlement; F2 — the RSUs were fully vested.
- Net effect in this filing: no net increase in shares held (acquired and disposed quantities are equal).
- Filing timeliness: no late-filing indication provided in the supplied data.
Context
The M code indicates an exercise or conversion of a derivative instrument; here it reflects RSU settlement into shares. The matching acquisition and disposition entries mean the filing shows conversion plus an immediate transfer/disposition of the same shares — the form does not specify the reason for the disposition (e.g., sale, transfer, or other settlement/withholding). This is a routine reporting of equity settlement rather than an open-market purchase or sale that clearly signals buying or selling intent.
Insider Transaction Report
- Exercise/Conversion
Common Stock
2026-04-30+3,403→ 8,947 total - Exercise/Conversion
Restricted Stock Units
[F1][F2]2026-04-30−3,403→ 0 totalExp: 2035-04-30→ Common Stock (3,403 underlying)
Footnotes (2)
- [F1]Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
- [F2]The RSUs are fully vested.